Abstract
The strategy of damage control resuscitation for a trauma patient in hemorrhagic shock involves preserving end-organ perfusion and preventing any further progression of the lethal triad of death; hypothermia, acidosis, and coagulopathy, which is commonly associated with hemorrhagic shock (Schreiber, Care Crit Curr Opin 11:590, 2005). Trauma patients are treated with surgical maneuvers to control bleeding, pharmacologic therapies to reduce bleeding, and by replacement of lost blood volume with blood products.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schreiber MA. Coagulopathy in the trauma patient. Curr Opin Crit Care. 2005;11:590.
American College of Surgeons Committee on Trauma. ATLS advanced trauma life support student course manual. 10th ed. Chicago: American College of Surgeons; 2018.
Moore EE, Feliciano DV, Mattox KL. Trauma. 8th ed. New York: McGraw-Hill; 2017.
Duchesne JC, Heaney J, Guidry C, et al. Diluting the benefits of hemostatic resuscitation: a multi-institutional analysis. J Trauma Acute Care Surg. 2013;751:76.
Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471.
Kornblith LZ, Howard BM, Cheung CK, et al. The whole is greater than the sum of its parts: hemostatic profiles of whole blood variants. J Trauma Acute Care Surg. 2014;77:818.
Cannon JW, Khan MA, Raja AS, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the surgery of trauma. J Trauma Acute Care Surg. 2017;82:605.
Roberts I. Tranexamic acid in trauma: how should we use it? J Thromb Haemost. 2015;13(Suppl. 1):S195–S9.
Takada A, Makino Y, Takada Y. Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysis. Thromb Res. 1986;42:39–47.
Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.
Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. B J Surg. 2013;100:1271–9.
Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomized controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79. https://doi.org/10.3310/hta17100.
CRASH-2 Collaborators I, Roberts HS, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet. 2011;377(9771):1096–101. 21439633.
Roberts I, Pablo P, David P-M, Haleema S, Tim C, Hunt Beverley J, et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomized controlled trial. BMJ. 2012;345:e5839.
“Lysteda (tranexamic acid) Package Insert” (PDF). accessdata.FDA.gov. Retrieved 20 June 2019.
Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(6 Suppl):S3–11.
Perez P, Salmi LR, Folléa G, Schmit JL, de Barbeyrac B, Sudre P, Salamon R, BACTHEM Group. French haemovigilance network. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM case-control study. Transfusion. 2001 Jul;41(7):862–72.
Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 1999;319(7201):16–9.
Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41(12):1493–9.
Menis M, Forshee RA, Anderson SA, McKean S, Gondalia R, Warnock R, Johnson C, Mintz PD, Worrall CM, Kelman JA, Izurieta HS. Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012. Vox Sang. 2015 Apr;108(3):251–61.
Blundell J. Experiments on the transfusion of blood by the syringe. Med Chir Trans. 1818;9(Pt 1):56–92.
Highmore W. Practical remarks on an overlooked source of blood supply for transfusion in post-partum haemorrhage suggested by a recent fatal case. Lancet. 1874;103:89–90.
Halsted WS. Refusion in carbonic-oxide poisoning. New York J Med. 1883;38:625–9.
Duncan J. On re-infusion of blood in primary and other amputations. Br Med J. 1886;1:192–3.
Thies HJ. Zur Behandlung der Extrauteringravidität. Zentralbl Gynäkol. 1914;38:1191–3.
Griswald RA, Ortner AB. Use of autotransfusion in surgery of serous cavities. Surg Gynecol Obstet. 1943;77:167–77.
Klebanoff G. Early clinical experience with a disposable unit for the intraoperative salvage and reinfusion of blood loss (intraoperative autotransfusion). Am J Surg. 1970;120:718–22.
Wilson JD, Taswell HF. Autotransfusion: historical review and preliminary report on a new method. Mayo Clin Proc. 1968;43(1):26–35.
Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010;4:CD001888.
Garcia JH, Coelho GR, Feitosa Neto BA, Nogueira EA, Teixeira CC, Mesquita DF. Liver transplantation in Jehovah’s witnesses patients in a center of northeastern Brazil. Arq Gastroenterol. 2013;50(2):138–40.
Waters JH. Indications and contraindications of cell salvage. Transfusion. 2004;44(12 Suppl):40S–4S.
Esper SA, Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus. 2011;9(2):139–47.
Sikorski RA, Rizkalla NA, Yang WW, Frank SM. Autologous blood salvage in the era of patient blood management. Vox Sang. 2017;112:499–510.
White NJ. Mechanism of trauma-induced coagulopathy. Hematology Am Soc Hematol Educ Program. 2013;2013:660–3.
Mohamed, et al. Scand J Trauma Resusc Emerg Med 2017: 25:99.
Adelfattah K, Cripps MW. Thromboelastography and rotational thromboelastometry use in trauma. Int J Surg. 2016;33:196–201.
Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma Acute Care Surg. 2003; Jun 1;54(6):1127–30.
Khan S, Brohi K, Chana M, Raza I, Stanworth S, Gaarder C, Davenport R. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg. 2014;76(3):561–8.
Howley IW, Haut ER, Jacobs L, et al. Is thromboelastography (TEG)-based resucitation better than empirical 1:1 transfusion? Trauma Surg Acute Care Open. 2018;3:1–3.
Schochl H, Maegele M, Solomnon C, Gorlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012;20:15.
Kashuk J, Moore E, Sawyer M, et al. Post injury coagulopathy management: goal directed resuscitation via POC thromboelastography. Ann Surg. 2010;251(4):604–14.
Massaro A, Doerfler S, Nawalinski K, et al. Thromboelastography defines late hypercoagulability after TBI: a pilot study. Neurocrit Care. 2015;22:45–51.
Mitra B, Cameron P, Gruen R. Aggressive fresh frozen plasma (FFP) with massive blood transfusion in the absence of acute traumatic coagulopathy. Injury. 2012;43(1):33–7.
Gruen R, Jacobs I, Reade M. Trauma and tranexamic acid. Med J Aus. 2013;199(5):310–1.
Walsh M, Fritz S, Hake D, Son M, et al. Targeted Thromboelastographic (TEG) blood component and pharmacologic hemostatic therapy in traumatic and acquired coagulopathy. Curr Drug Targets. 2016;17:954–70.
Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol. 2009;147:431.
Meyer DE, Reynolds JW, Hobbs R, et al. The incidence of transfusion-related acute lung injury at a large, Urban Tertiary Medical Center: a decade’s experience. Anesth Analg. 2018;127:444.
Patel SV, Kidane B, Klingel M, et al. Risks associated with red blood cell transfusion in the trauma population, a meta-analysis. Injury. 2014;45:1522.
Jones AR, Patel RP, Marques MB, et al. Older blood is associated with increased mortality and adverse events in massively transfused trauma patients: secondary analysis of the PROPPR trial. Ann Emerg Med. 2019;73:650.
Vraets A, Lin Y, Callum JL. Transfusion-associated hyperkalemia. Transfus Med Rev. 2011;25:184.
Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137:209.
Perlman R, Callum J, Laflamme CA, et al. A recommended early goal-directed management guideline for the prevention of hypothermia-related transfusion, morbidity, and mortality in severely injured trauma patients. Crit Care. 2016;20:107.
ThermaCor 1200 rapid infusion device website. https://www.thermacor1200.com/company-info.cms. Accessed 10 Jul 2019.
Level 1 rapid infusion device website. https://www.smiths-medical.com/products/temperature-management/blood-and-fluid-warming-systems/fast-flow-fluid-warming-trauma/level-1-h1200-fast-flow-fluid-warmer-with-integrated-air-detectorclamp. Accessed 10 Jul 2019.
Belmont rapid infusion device website. http://www.eostip.com/imgs/pdf/pdf_1_10.pdf. Accessed 10 Jul 2019.
Cumunale ME. A laboratory evaluation of the level 1 rapid infuser (H1025) and the Belmont instrument fluid management system (FMS 2000) for rapid transfusion. Anesth Analg. 2003;97:1064–9.
Barcelona SL, Vilich F, Cote CJ. A comparison of flow rates and warming capabilities of the level 1 and rapid infusion system with various-size intravenous catheters. Anes Analg. 2003;97:358–63.
Wrenn EA, Wohlers R, Montgomery M, et al. Comparison of flow dynamics of peripherally and centrally inserted intravenous catheters using a rapid infusion system (ThermaCor1200). AANA. 2017;85(4):256–60.
Buck A. Large bore IV access showdown: do you know which IV cannula can deliver fluid to your patient the fastest? ETM Course. https://etmcourse.com/large-bore-iv-access-showdown/. Accessed 15 Jul 2019.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Humanez, J.C., Oshikoya, O., Hsu, A., Hoefnagel, A.L. (2021). Blood Transfusion in the Severe Trauma Patient. In: Scher, C.S., Kaye, A.D., Liu, H., Perelman, S., Leavitt, S. (eds) Essentials of Blood Product Management in Anesthesia Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-59295-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-59295-0_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-59294-3
Online ISBN: 978-3-030-59295-0
eBook Packages: MedicineMedicine (R0)